Abstract:
Aim of the study. To evaluate the relationship between pulmonary artery pressure and hydration status in patients undergoing
hemodialysis, and to assess the effect of achieving optimal dry weight on the dynamics of pulmonary hypertension. Material
and methods. A total of 52 patients (20 males and 32 females; mean age 55±12 years) with stage 5 chronic kidney disease
(CKD) on maintenance hemodialysis (HD) were prospectively enrolled. Hydration status and dry weight were assessed by
multifrequency bioimpedance analysis (ABC-01 device, MEDAS, Sport-5 software). Pulmonary artery pressure was evaluated
by Doppler echocardiography at baseline and after 12 months of HD therapy in accordance with European Society of Cardiology
criteria. Echocardiographic parameters included left ventricular mass index (LVMI), ejection fraction (EF), and systolic
pulmonary artery pressure (sPAP). Statistical analyses employed Student’s t-test and univariate correlation analysis; p<0.05
was considered statistically significant. Results. Pulmonary hypertension (PH) was detected in 58% of patients. After one year
of HD, sPAP decreased from 46.3±16.1 to 40.4±11.7 mmHg (p<0.01), LVMI declined from 159.1±35.8 to 129.1±42.2 g/m²
(p<0.05), and hemoglobin improved from 106.5±18.7 to 113.9±11.5 g/L (p<0.01). Mean total body water (TBW) was 34.1±6.5
L; extracellular water (ECW) was 21.5±4.4 L. A significant positive correlation was found between ECW and sPAP (r=0.4;
p<0.01). No statistically significant relationship was found between arteriovenous (AV) fistula blood flow and pulmonary artery
pressure. Conclusion. PH in HD patients at initiation of therapy is closely associated with left ventricular hypertrophy, impaired
systolic function, and anemia. After one year of maintenance HD, significant regression of PH and left ventricular hypertrophy
(LVH) was observed, attributable to improved volume control and anemia correction. AV fistula function does not independently
contribute to PH severity. Bioimpedance-guided hydration monitoring is an important tool for cardiovascular risk reduction in
this population.